Propriedade intelectual e doenças negligenciadas: um estudo de caso da Leishmaniose à luz do sistema jurídico de patentes
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Some diseases are classified as neglected because they mainly affect a poorer
consumer market, representing low potential financial returns for the pharmaceutical
industry, even though they are responsible for more than a billion cases in 149
countries. The list of neglected diseases includes Leishmaniasis, an endemic disease
in Brazil and Minas Gerais. There is still no vaccine for leishmaniasis in humans, whose
treatment is highly toxic. Leishmaniasis-positive dogs are usually euthanized, as there
is no cure for the disease in canines and they can transmit it to humans. The aim is to
see how the effects of the legal patent system are related, from an innovation policy
perspective, based on the case study of leishmaniasis, a neglected disease,
considering the profile of the applicants, the purpose of the filings and the status of the
patent applications collected from the INPI database. "The theory proposed by
Bankowski served as a guiding principle for this research.". The analysis gathered and
studied all available patent application files from the INPI, to verify the profile of the
applicants, the purpose of the inventions, the status of the patent applications and the
use of the priority processing prerogative. The patent legal system does not promote
innovation for neglected diseases like Leishmaniasis due to the limited financial gain
associated with researching and developing treatments for a disease that primarily
affects low-income populations. It seems that there was little interest from the private
sector in developing innovations related to the disease, leading to a high concentration
of research and development in public universities, particularly those located in Minas
Gerais due to the endemic nature of the disease in the state. Most of the innovations
are aimed at treating the disease, reflecting the market's need to look for less toxic
treatments. The lack of interest from the private sector in developing innovations
related to Leishmaniasis has led to a high concentration of research and development
in public universities. The legal patent system also reflects the neglected nature of the
disease, failing to fulfill its original aspiration. This highlights the need to reformulate
public policies aimed at the public health problem that is Leishmaniasis in the country.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

